Trends in mortality due to invasive mycotic diseases in the United States, 1980-1997

Clinical Infectious Diseases

Volumn 33, Issue 5, 2001, Pages 641-647

  McNeil, Michael M ^a   Nash, Stephanie L ^a   Hajjeh, Rana A ^a   Phelan, Maureen A ^a   Conn, Laura A ^b   Plikaytis, Brian D ^a   Warnock, David W ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b NATL CENTER FOR INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE; AGED; CAUSE OF DEATH; CELL INVASION; CHILD; DEATH CERTIFICATE; DISEASE CLASSIFICATION; FEMALE; HEALTH SURVEY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; INFANT; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MORTALITY; MYCOSIS; NEWBORN; PRIORITY JOURNAL; RACE DIFFERENCE; REVIEW; UNITED STATES;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AIDS-RELATED OPPORTUNISTIC INFECTIONS; CHEMOPREVENTION; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; MORTALITY; MYCOSES; OPPORTUNISTIC INFECTIONS; POPULATION SURVEILLANCE; RISK FACTORS; SEX DISTRIBUTION; UNITED STATES;

EID: 0035451130     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/322606     Document Type: Article

References (34)

1. Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990
2. Epidemiology of nosocomial fungal infections
3. Effect of the human immunodeficiency virus epidemic on mortality from opportunistic infections in the United States in 1993
4. The epidemiological features of invasive mycotic infections in the San Francisco Bay area, 1992-1993: Results of population-based laboratory active surveillance
5. The epidemiology of candidemia in two United States cities: Results of a population-based active surveillance
6. Cryptococcosis: Population-based multistate active surveillance and risk factors in human immunodeficiency virus-infected persons
7. Trends in infectious diseases mortality in the United States
8. Advance report of final mortality statistics, 1993
9. Trends in infectious disease mortality in the United States during the 20th century
10. The role of postmortem examination in medical education
11. Guidelines for prophylaxis against Pneumocystis carinii pneumonia for persons infected with human immunodeficiency virus
12. Discontinuation of Pneumocystis carinii pneumonia prophylaxis after start of highly active antiretroviral therapy in HIV-1 infection
13. Declining rates of oropharyngeal candidiasis and carriage of Candida albicans associated with trends toward reduced rates of carriage of fluconazole-resistant C. Albicans in human immunodeficiency virus-infected patients
14. Reduction in oropharyngeal candidiasis following introduction of protease inhibitors
15. Frequency of oropharyngeal candidiasis in HIV-infected patients on protease inhibitor therapy
16. Effect of highly active antiretroviral therapy on recurrent oropharyngeal candidiasis in HIV-infected patients
17. Resolution of azole-resistant oropharyngeal candidiasis after initiation of potent combination antiretroviral therapy
18. Role of protease inhibitors in preventing recurrent oral candidosis in patients with HIV infection: A prospective case-control study
19. Withdrawal of fluconazole suppressive therapy for thrush in patients responding to combination antiviral therapy including protease inhibitors
20. HIV protease inhibitors influence the prevalence of oral candidosis in HIV-infected patients: A 2-year study
21. Increased incidence of fungemia caused by Candida krusei
22. Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole
23. Association of Torulopsis glabrata infections with fluconazole prophylaxis in neutropenic bone marrow transplant patients
24. A coccidioidomycosis outbreak following the Northridge, California, earthquake
25. Coccidioidomycosis in Tulare County, California, 1991: Reemergence of an endemic disease
26. Coccidioidomycosis in Arizona: Increase in incidence from 1990 to 1995
27. A randomized trial of continuous or intermittent therapy with fluconazole for oropharyngeal candidiasis in HIV-infected patients: Clinical outcomes and development of fluconazole resistance
28. Weekly fluconazole for the prevention of mucosal candidiasis in women with HIV infection: A randomized, double-blind, placebo-controlled trial. Terry Beirn community programs for clinical research on AIDS
29. Prophylaxis with weekly versus daily fluconazole for fungal infections in patients with AIDS
30. 3: Demonstration of efficacy in a prospective, multicenter trial
31. Itraconazole prophylaxis for fungal infections in patients with advanced human immunodeficiency virus infection: Randomized, placebo-controlled, double-blind study
32. 1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus
33. Therapeutic outcome in invasive aspergillosis